NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









MyLife Technologies

MyLife Technologies

Private
LeidenHealthcare & Life Scienceshttps://mylifetechnologies.nl/

Last Round

Early Funding

Nov 12, 2021

Total Funding Raised

$4.95M

Company Overview

MyLife Technologies is a health technology company that develops innovative drug delivery systems, specifically nanoporous microneedle arrays (npMNAs) integrated into painless skin patches for vaccines and pharmaceuticals.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Advanced Materials, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

microneedle patchnanoporous microneedle arraynpMNAintradermal drug deliverypainless vaccine deliverydrug delivery platformneedle-free injectioncold-chain freevaccine stabilizationdose-sparing technologymedtechbiotechceramic medical devicesdrug delivery systems

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

MyLife Technologies Comparables

Compare MyLife Technologies with similar companies based on industry and business-model similarity.

MyLife Technologies comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
CeraVx B.V.
91%
Innoture
86%
Micron Biomedical
84%

MyLife Technologies Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingNov 12, 2021
GrantDec 16, 2019
SeedDec 3, 2018
Early FundingNov 14, 2016

Key People

Founding team and executive leadership

Jan Groen

Chief Executive Officer

Executive Team

Jelte Meulenaar

Chief Operating Officer

Executive Team

MyLife Technologies Investors

Notable investors and investment history

MyLife Technologies investors
InvestorRounds
EIT HealthGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 1, 2026

    Grew 50% QoQ from 6 to 9 employees.

  • Feb 25, 2025

    Grew 80% QoQ from 5 to 9 employees.

MyLife Technologies Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

MyLife Technologies Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about MyLife Technologies's valuation, stock price, and market status.

Firmographic Details

HeadquartersLeiden
Employee Range9
Year Founded2012
Last FundingNov 12, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.